Annovis Provides Corporate Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results Mar 21, 2025 05:05PM
Annovis Bio Inc. (ANVS) Closes $21M Offering Feb 4, 2025 04:31PM
Annovis Bio, Inc. Announces Closing of $21 Million Public Offering Feb 4, 2025 04:31PM
Annovis Bio, Inc. Announces Closing of $21 Million Public Offering Feb 4, 2025 04:31PM
Annovis Bio Inc. (ANVS) Prices 5.25M Share Offering at $4/sh Feb 3, 2025 06:23AM


Feb 3, 2025 06:22AM Annovis Bio, Inc. Announces Pricing of $21 Million Public Offering
Jan 31, 2025 08:14PM Annovis Bio, Inc. Announces Proposed Public Offering
Jan 31, 2025 08:14PM Annovis Bio, Inc. Announces Proposed Public Offering
Apr 11, 2023 09:04AM ANNOVIS BIO RAISES AGGREGATE GROSS PROCEEDS OF APPROXIMATELY $8.7 MILLION
Oct 20, 2022 07:30AM Annovis Bio to Present at the 2022 ThinkEquity Investor Conference
Jan 31, 2020 11:46AM Annovis Bio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jan 31, 2020 11:46AM Annovis Bio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jan 29, 2020 05:52AM Annovis Bio Inc. (ANVS) Prices 2M Share IPO at $6/Sh
Jan 28, 2020 11:31PM Annovis Bio Announces Pricing of Initial Public Offering